The GSTA1 polymorphism and cyclophosphamide therapy outcomes in lupus nephritis patients | |
Wang, Hong-Na; Zhu, Xiao-Ye; Zhu, Ying; Xie, Qiong-Hong; Lai, Lin-Yun; Zhao, Miao; Chen, Yuan-Cheng; Xue, Jun; Hao, Chuan-Ming; Gu, Yong | |
刊名 | CLINICAL IMMUNOLOGY
![]() |
2015 | |
卷号 | 160期号:2 |
关键词 | Cyclophosphamide GSTA1 Pharmacokinetics Pharmacogenomics Lupus nephritis |
ISSN号 | 1521-6616 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4868326 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Wang, Hong-Na,Zhu, Xiao-Ye,Zhu, Ying,et al. The GSTA1 polymorphism and cyclophosphamide therapy outcomes in lupus nephritis patients[J]. CLINICAL IMMUNOLOGY,2015,160(2). |
APA | Wang, Hong-Na.,Zhu, Xiao-Ye.,Zhu, Ying.,Xie, Qiong-Hong.,Lai, Lin-Yun.,...&Lin, Shan-Yan.(2015).The GSTA1 polymorphism and cyclophosphamide therapy outcomes in lupus nephritis patients.CLINICAL IMMUNOLOGY,160(2). |
MLA | Wang, Hong-Na,et al."The GSTA1 polymorphism and cyclophosphamide therapy outcomes in lupus nephritis patients".CLINICAL IMMUNOLOGY 160.2(2015). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论